未登录
分享
收藏
分享
收藏
分享
收藏Ensitrelvir as a novel treatment option for mild-to-moderate COVID-19: a narrative literature review
Mukae, Hiroshi; Yotsuyanagi, Hiroshi; Ohmagari, Norio; Doi, Yohei; Yamato, Masaya; Imamura, Takumi; Sakaguchi, Hiroki; Sanaki, Takao; Sonoyama, Takuhiro; Tsuge, Yuko; Uehara, Takeki
分享
收藏
分享
收藏
分享
收藏Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical TrialEnsetrelvir治疗无症状或轻度新型冠状病毒肺炎的疗效和安全性: 一项多中心、随机、2b/3期临床试验的探索性分析
Ohmagari, Norio; Yotsuyanagi, Hiroshi; Doi, Yohei; Yamato, Masaya; Imamura, Takumi; Sakaguchi, Hiroki; Yamanaka, Hideki; Imaoka, Ryosuke; Fukushi, Akimasa; Ichihashi, Genki; Sanaki, Takao; Tsuge, Yuko; Uehara, Takeki; Mukae, Hiroshi
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19): The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 StudyEnsetrelvir在轻中度冠状病毒疾病患者中的疗效和安全性2019 (新型冠状病毒肺炎): 一项随机,安慰剂对照,2/3期研究的2b期部分
Mukae, Hiroshi; Yotsuyanagi, Hiroshi; Ohmagari, Norio; Doi, Yohei; Sakaguchi, Hiroki; Sonoyama, Takuhiro; Ichihashi, Genki; Sanaki, Takao; Baba, Keiko; Tsuge, Yuko; Uehara, Takeki
分享
收藏
分享
收藏
分享
收藏